Andreas Halvorsen: portfolio of Viking Global Investors
Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.
Source: 13F filing with the US Securities and Exchange Commission dated Aug 14, 2025. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q2 2025. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 34.6B USD
- Positions
- 83
- Share of the ten largest
- 31.1%
The ten largest positions Q2 2025
- Bank of America 4.3%▼ −3.0%
- Charles Schwab Corporation 4.2%▼ −11.0%
- Capital One 3.5%▲ +23.5%
- JPMorgan Chase 3.4%▲ +86.1%
- U.S. Bancorp 3.2%▼ −30.9%
- Taiwan Semiconductor Manufacturing (ADR) 2.8%▼ −11.5%
- Mcdonalds Corp 2.6%▲ +171.7%
- Amazon 2.5%▲ +43.2%
- Fortive 2.4%▲ +22.9%
- Bridgebio Pharma Inc 2.3%▼ −15.9%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q2 2025
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| BAC Bank of America | 4.3% | 31,246,972 | 1.5B USD | −3.0% reduced | Q3 2024 4 quarters |
| SCHW Charles Schwab Corporation | 4.2% | 15,773,225 | 1.4B USD | −11.0% reduced | Q3 2024 4 quarters |
| COF Capital One | 3.5% | 5,671,358 | 1.2B USD | +23.5% increased | Q1 2025 2 quarters |
| JPM JPMorgan Chase | 3.4% | 4,042,034 | 1.2B USD | +86.1% increased | Q2 2024 5 quarters |
| USB U.S. Bancorp | 3.2% | 24,089,428 | 1.1B USD | −30.9% reduced | Q4 2023 7 quarters |
| TSM Taiwan Semiconductor Manufacturing (ADR) | 2.8% | 4,329,295 | 980.5M USD | −11.5% reduced | Q4 2024 3 quarters |
| Mcdonalds Corp | 2.6% | 3,125,432 | 913.2M USD | +171.7% increased | Q1 2025 2 quarters |
| AMZN Amazon | 2.5% | 3,897,092 | 855.0M USD | +43.2% increased | Q2 2015 41 quarters |
| FTV Fortive | 2.4% | 15,912,624 | 829.5M USD | +22.9% increased | Q3 2019 24 quarters |
| Bridgebio Pharma Inc | 2.3% | 18,555,375 | 801.2M USD | −15.9% reduced | Q2 2019 25 quarters |
| DIS Walt Disney Company (The) | 2.1% | 5,848,066 | 725.2M USD | new | Q2 2025 1 quarter |
| HCA HCA Healthcare | 2.1% | 1,872,133 | 717.2M USD | +58.5% increased | Q4 2023 7 quarters |
| TMUS T-Mobile US | 2.0% | 2,845,316 | 677.9M USD | +81.7% increased | Q4 2023 7 quarters |
| Biomarin Pharmaceutical Inc | 2.0% | 12,288,611 | 675.5M USD | +13.8% increased | Q4 2021 15 quarters |
| SHW Sherwin-Williams | 1.9% | 1,957,750 | 672.2M USD | +101.4% increased | Q2 2024 5 quarters |
| Flutter Entmt PLC | 1.9% | 2,284,905 | 652.9M USD | −10.5% reduced | Q3 2024 4 quarters |
| GM General Motors | 1.9% | 13,018,874 | 640.7M USD | +81.1% increased | Q4 2024 3 quarters |
| PM Philip Morris International | 1.8% | 3,454,186 | 629.1M USD | +7.5% increased | Q2 2023 9 quarters |
| COR Cencora | 1.8% | 2,081,732 | 624.2M USD | +95.0% increased | Q1 2025 2 quarters |
| AMT American Tower | 1.8% | 2,797,125 | 618.2M USD | +233.5% increased | Q4 2024 3 quarters |
| CSX CSX Corporation | 1.8% | 18,871,882 | 615.8M USD | +10.6% increased | Q4 2022 11 quarters |
| APD Air Products | 1.8% | 2,154,154 | 607.6M USD | new | Q2 2025 1 quarter |
| ROST Ross Stores | 1.8% | 4,747,639 | 605.7M USD | +9.9% increased | Q4 2024 3 quarters |
| BA Boeing | 1.7% | 2,835,065 | 594.0M USD | −12.3% reduced | Q4 2024 3 quarters |
| Api Group Corp | 1.7% | 11,537,518 | 589.0M USD | −46.4% reduced | Q2 2020 21 quarters |
| NVDA Nvidia | 1.7% | 3,681,935 | 581.7M USD | −43.7% reduced | Q2 2024 5 quarters |
| Primo Brands Corporation | 1.7% | 19,602,116 | 580.6M USD | +290.2% increased | Q1 2025 2 quarters |
| V Visa Inc. | 1.7% | 1,620,722 | 575.4M USD | −23.7% reduced | Q3 2024 4 quarters |
| DHR Danaher Corporation | 1.7% | 2,907,515 | 574.4M USD | +543.9% increased | Q1 2025 2 quarters |
| SE Sea Limited (ADR) | 1.6% | 3,536,987 | 565.7M USD | −15.0% reduced | Q1 2025 2 quarters |
| QCOM Qualcomm | 1.5% | 3,152,866 | 502.1M USD | +120.1% increased | Q4 2024 3 quarters |
| Regal Rexnord Corporation | 1.4% | 3,430,128 | 497.2M USD | +25.7% increased | Q4 2023 7 quarters |
| NKE Nike, Inc. | 1.4% | 6,967,198 | 494.9M USD | +25.6% increased | Q1 2025 2 quarters |
| PNC PNC Financial Services | 1.3% | 2,375,664 | 442.9M USD | new | Q2 2025 1 quarter |
| Roivant Sciences Ltd | 1.1% | 34,237,779 | 385.9M USD | −25.6% reduced | Q4 2021 15 quarters |
| Acuren Corp | 1.1% | 34,360,000 | 379.3M USD | unchanged | Q1 2025 2 quarters |
| FSLR First Solar | 1.1% | 2,266,050 | 375.1M USD | +60.6% increased | Q1 2025 2 quarters |
| CCL Carnival Corporation | 1.1% | 13,207,267 | 371.4M USD | +6.4% increased | Q1 2025 2 quarters |
| XYZ Block, Inc. | 1.1% | 5,420,475 | 368.2M USD | new | Q2 2025 1 quarter |
| DHI D. R. Horton | 1.1% | 2,827,032 | 364.5M USD | +108.3% increased | Q1 2025 2 quarters |
| CVNA Carvana | 1.1% | 1,077,976 | 363.2M USD | −57.8% reduced | Q2 2024 5 quarters |
| Ferrari NV | 1.0% | 721,269 | 353.5M USD | +432.7% increased | Q1 2025 2 quarters |
| TSLA Tesla, Inc. | 1.0% | 1,100,331 | 349.5M USD | +214.3% increased | Q1 2025 2 quarters |
| Adaptive Biotechnologies Cor | 1.0% | 29,993,708 | 349.4M USD | unchanged | Q2 2019 25 quarters |
| BSX Boston Scientific | 0.9% | 3,045,764 | 327.1M USD | +28.1% increased | Q3 2024 4 quarters |
| LLY Lilly (Eli) | 0.9% | 416,918 | 325.0M USD | new | Q2 2025 1 quarter |
| CMG Chipotle Mexican Grill | 0.9% | 5,688,483 | 319.4M USD | −5.3% reduced | Q1 2025 2 quarters |
| CPT Camden Property Trust | 0.9% | 2,716,022 | 306.1M USD | −2.6% reduced | Q1 2024 6 quarters |
| LEN Lennar | 0.8% | 2,523,594 | 279.1M USD | +86.7% increased | Q1 2025 2 quarters |
| AMD Advanced Micro Devices | 0.8% | 1,910,571 | 271.1M USD | new | Q2 2025 1 quarter |
| CSGP CoStar Group | 0.7% | 3,218,568 | 258.8M USD | new | Q2 2025 1 quarter |
| Ralliant Corp | 0.7% | 5,304,195 | 257.2M USD | new | Q2 2025 1 quarter |
| Gallagher Arthur J & Co | 0.7% | 725,795 | 232.3M USD | +8.9% increased | Q1 2025 2 quarters |
| Saia Inc | 0.7% | 827,659 | 226.8M USD | new | Q2 2025 1 quarter |
| BLK BlackRock | 0.6% | 195,104 | 204.7M USD | new | Q2 2025 1 quarter |
| META Meta Platforms | 0.6% | 265,499 | 196.0M USD | −81.9% reduced | Q1 2025 2 quarters |
| Teva Pharmaceutical Inds Ltd | 0.6% | 11,681,333 | 195.8M USD | +15.4% increased | Q3 2024 4 quarters |
| TTD The Trade Desk | 0.6% | 2,674,320 | 192.5M USD | new | Q2 2025 1 quarter |
| Maplebear Inc | 0.5% | 3,752,924 | 169.8M USD | new | Q2 2025 1 quarter |
| CME CME Group | 0.5% | 597,374 | 164.6M USD | new | Q2 2025 1 quarter |
| Integer HLDGS Corp | 0.5% | 1,283,965 | 157.9M USD | +9.1% increased | Q1 2024 6 quarters |
| AIG American International Group | 0.4% | 1,815,785 | 155.4M USD | new | Q2 2025 1 quarter |
| JCI Johnson Controls | 0.4% | 1,450,812 | 153.2M USD | new | Q2 2025 1 quarter |
| Amer Sports Inc | 0.4% | 3,880,649 | 150.4M USD | +64.8% increased | Q1 2025 2 quarters |
| APP AppLovin | 0.4% | 372,973 | 130.6M USD | +172.1% increased | Q4 2024 3 quarters |
| Masimo Corp | 0.4% | 767,426 | 129.1M USD | new | Q2 2025 1 quarter |
| Newamsterdam Pharma Company | 0.4% | 6,978,534 | 126.4M USD | unchanged | Q4 2022 11 quarters |
| Ryan Specialty Holdings Inc | 0.3% | 1,412,767 | 96.1M USD | +47.8% increased | Q1 2025 2 quarters |
| Royalty Pharma PLC | 0.3% | 2,597,460 | 93.6M USD | −75.4% reduced | Q2 2020 21 quarters |
| UBS Group AG | 0.3% | 2,580,412 | 87.3M USD | new | Q2 2025 1 quarter |
| Molina Healthcare Inc | 0.2% | 267,421 | 79.7M USD | new | Q2 2025 1 quarter |
| Standard Biotools Inc | 0.2% | 58,651,170 | 70.4M USD | unchanged | Q1 2024 6 quarters |
| Oric Pharmaceuticals Inc | 0.2% | 6,572,700 | 66.7M USD | unchanged | Q1 2024 6 quarters |
| Pharvaris N V | 0.2% | 3,653,310 | 64.3M USD | unchanged | Q1 2021 18 quarters |
| Sionna Therapeutics Inc | 0.2% | 3,195,181 | 55.4M USD | +8.2% increased | Q1 2025 2 quarters |
| Metsera Inc | 0.1% | 1,616,612 | 46.0M USD | unchanged | Q1 2025 2 quarters |
| Ginkgo Bioworks Holdings Inc | 0.1% | 3,577,128 | 40.2M USD | unchanged | Q3 2024 4 quarters |
| Inhibrx Biosciences Inc | < 0.1% | 1,787,705 | 25.5M USD | unchanged | Q2 2024 5 quarters |
| Healthequity Inc | < 0.1% | 219,746 | 23.0M USD | new | Q2 2025 1 quarter |
| Establishment Labs HLDGS Inc | < 0.1% | 343,465 | 14.7M USD | new | Q2 2025 1 quarter |
| Trevi Therapeutics Inc | < 0.1% | 1,543,000 | 8.4M USD | −52.2% reduced | Q3 2022 12 quarters |
| Pepgen Inc | < 0.1% | 1,482,434 | 1.6M USD | unchanged | Q2 2022 13 quarters |
| Rallybio Corp | < 0.1% | 4,194,777 | 1.4M USD | unchanged | Q3 2021 16 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Breakdown by sector
- Financials 24.0%
- Consumer Discretionary 13.4%
- Technology 7.8%
- Health Care 7.4%
- Industrials 6.3%
- Communication Services 5.0%
- Materials 3.7%
- Real Estate 3.4%
- Consumer Staples 1.8%
- not in our coverage 27.0%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors